Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size has experienced significant expansion in recent years. It is anticipated to grow from $6.2 billion in 2025 to $7.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. The historical growth in this market can be attributed to several factors, including the initial limited availability of specialized cdmo services, increasing research and development investment in advanced therapies, the early adoption of gene and cell therapies, a rising prevalence of complex diseases, and the proliferation of small biotech startups.
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market is projected for swift expansion in the coming years. This market is set to reach $12.55 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.8%. This expansion over the forecast period is fueled by several factors, including progress in scalable manufacturing technologies, more frequent partnerships between cdmos and pharmaceutical companies, the proliferation of autologous and allogeneic therapies, increasing worldwide need for personalized medicine, and market entry into developing regions. Key trends during this period encompass a heightened need for cdmo services in the creation of advanced therapies, the broader development of gene, cell, and tissue engineered therapies, a stronger emphasis on adhering to regulations and quality benchmarks, an increase in outsourced production for biopharmaceutical firms, and the implementation of adaptable manufacturing platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp
What Drivers Are Influencing The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products CDMO market is anticipated to expand due to the growing volume of clinical trials. These trials are human-based research investigations designed to assess the safety and effectiveness of various medical interventions, including medications, therapies, devices, or preventative measures. The escalating count of clinical trials reflects a greater need for groundbreaking treatments and an effort to tackle the increasing worldwide burden of diseases. As advanced therapy medicinal products are utilized, the need for CDMO manufacturing support grows, relying on specialized skills and facilities. Information gathered from clinical trials helps streamline manufacturing, guarantee scalability, and uphold quality to satisfy broader clinical and commercial requirements. For instance, in July 2024, according to the Royal Pharmaceutical Society, a UK-based professional membership body, the number of people recruited to clinical trials in the UK in 2023/2024 was 349,019, an increase from 342,390 people in 2022/2023. Consequently, the rising number of clinical trials is propelling the expansion of the advanced therapy medicinal products CDMO market.
What Major Segment Divisions Exist Within The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs
How Are Trends Shaping The Direction Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Leading companies within the advanced therapy medicinal products CDMO market are actively developing sophisticated cell therapy manufacturing services. These initiatives aim to address significant challenges in cell therapy production and accelerate the development timelines for their partners. Such cell therapy manufacturing services encompass contract development and manufacturing organization offerings, extending from initial preclinical development through advanced clinical trials and ultimately to commercialization. As an illustration, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company specializing in cellular solutions, introduced PluriCDMO. This new business division focuses on providing cell therapy manufacturing capabilities. PluriCDMO employs a proprietary bioreactor system designed for 3D cell multiplication, enabling the production of diverse cell types including stem cells, induced pluripotent stem cells, exosomes, and immune therapies. The division’s aspiration is to deliver essential, high-quality medicines to patients, ensuring exceptional batch-to-batch consistency in a scalable and economically efficient manner, all within good manufacturing practice environments.
Which Companies Are Leading Innovation In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Read the full advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
topical drugs contract development and manufacturing organization cdmo global market report
pharmaceutical contract developments and manufacturing organization cmo global market report
cell and gene therapy contract development and manufacturing organization cdmo global market report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
